IP Verse

Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab - EP2676967

PATENT ANALYSIS

Patent Details

Grant Date
Aug 14, 2019
Company
BIOGEN IDEC MA INC.
Oppositions

POLPHARMA BIOLOGICS S.A.

More patents of Biogen Idec Ma Inc.

EP2645106

EP2701778

EP2653873

Want to monitor this patent?

Feel free to send us a message here and we will get back to you